Biz Focus Hub
Markets
Business
Investing
Technology
Financial Insights
More
Politics
World
Opinion
Mobile menu
Menu
Biz Focus Hub
Markets
Business
Investing
Technology
Financial Insights
More
Politics
World
Opinion
Copyright
Biz Focus Hub
- All right reserved
Annika Kim Constantino
The FDA authorizes Bristol Myers Squibb's novel schizophrenia medication, marking a significant advancement in treatment options after years.
Business News
A study suggests that Novo Nordisk's diabetes drug Ozempic may decrease the likelihood of opioid overdoses.
Business News
The CEO of Novo Nordisk will appear before the Senate to discuss the high cost of weight loss drugs.
Business News
Allegations of Inflating Insulin Prices Lead to FTC Lawsuit against Drug Middlemen
Business News
Competitive Edge: Can Roche Succeed in the Weight Loss Drug Industry?
Business News
Pfizer reports positive trial results for experimental drug targeting deadly condition causing appetite and weight loss in cancer patients.
Business News
Moderna to reduce expenses by $1.1 billion and introduce 10 new products by 2027 as it plans for the post-Covid era.
Business News
Eli Lilly Announces $1.8 Billion Investment in Manufacturing for Weight Loss, Diabetes, and Alzheimer's Drugs
Business News
GLP-1 Drugs: Over 50 Million Privately Insured Adults May Be Eligible
Business News
Patients with Alzheimer's disease may receive more time with a new drug, but they must navigate a lengthy path to treatment.
Business News
Eli Lilly on Track to Become First $1 Trillion Health-Care Stock
Business News
The FDA approves Novavax's updated Covid-19 vaccine, clearing the path for an autumn distribution.
Business News
The Latest Round of Pfizer and Moderna Covid Vaccines: What You Need to Know
Business News
Eli Lilly reduces price of Zepbound weight loss drug to increase availability and distribution.
Business News
The U.S. will provide free at-home Covid tests once more from late September.
Business News
Updated Pfizer and Moderna Covid vaccines approved by FDA; shots to be available soon.
Business News
Sesame Health-Care System to Launch New $249 Weight Loss Program with Compounded Wegovy Versions
Business News
The competition to create combination treatments for Covid-19 and the flu is intensifying.
Business News
In a long-term trial, Eli Lilly's weight loss drug significantly reduces the likelihood of developing diabetes.
Business News
What is the cause of Walgreens and CVS retail pharmacies' struggles, and how are they addressing the issue?
Business News
What are the plans for the Biden administration's Medicare drug price negotiations?
Business News
Medicare negotiations: Biden administration to reveal prices for first 10 drugs
Business News
Novo Nordisk Faces Increasing Competition from Eli Lilly in Weight Loss Drug Market
Business News
Eli Lilly surpasses expectations, raises forecasts with Zepbound and Mounjaro sales increasing
Business News
Top Aetna executive to depart as CVS lowers profit outlook due to rising medical costs.
Business News
Medicare Negotiations: Drugmakers' Final Price Statements
Business News
The FDA has announced that Eli Lilly's Zepbound and Mounjaro are now available in the US after shortages.
Business News
In a late-stage study, Eli Lilly's weight loss drug Zepbound reduced the risk of heart failure.
Business News
Biogen surpasses expectations, raises forecast due to the growing popularity of Leqembi and other new products.
Business News
Moderna's stock drops over 10% after cutting EU sales forecast and facing challenges in the US vaccine market.
Business News
GLP-1s: Beyond Weight Loss and Diabetes, What Healthy Returns are Being Tested for
Business News
Eisai study reveals that patients on Alzheimer's drug Leqembi experience benefits over three years.
Business News
Study suggests that an older GLP-1 drug from Novo Nordisk can slow Alzheimer's disease progression by protecting the brain.
Business News
Pfizer surpasses earnings expectations and raises its full-year forecast after reducing expenses.
Business News
Merck surpasses earnings expectations and boosts sales forecast due to high demand for top drugs such as Keytruda.
Business News
Biogen and Eisai's Alzheimer's treatment Leqembi is rejected by the European drug regulator.
Business News
Bristol Myers Squibb surpasses earnings expectations and enhances its forecast after cutting expenses.
Business News
The weight loss injection by Viking Therapeutics experiences a 16% increase in stock value following its transition to a late-stage trial.
Business News
A late-stage trial of Pfizer's gene therapy for a rare genetic bleeding disorder has been successful.
Business News
Medicare Drug Price Negotiations: The First Round is Almost Over
Business News
Bipartisan bill introduced to combat drug middlemen as scrutiny intensifies.
Business News